Targeting the fetal acetylcholine receptor in rhabdomyosarcoma

Strategies to Overcome Obstacles to Successful Immunotherapy of Melanoma

(2017) F. Pandolfi et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Immunotherapy of cancer in 2012

(2012) John M. Kirkwood et al.   CA-A CANCER JOURNAL FOR CLINICIANS

AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell

(2012) Mathivanan Jothi et al.   CELL CYCLE

A set of imprinted genes required for normal body growth also promotes growth of rhabdomyosarcoma cells

(2012) Geoffrey Rezvani et al.   PEDIATRIC RESEARCH

Antibody Fusion Proteins: Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox

(2011) R. J. Kreitman et al.   CLINICAL CANCER RESEARCH

Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases

(2011) Haya Lorberboum-Galski   Expert Opinion on Drug Delivery

Marking the tempo for myogenesis: Pax7 and the regulation of muscle stem cell fate decisions

(2011) Hugo C. Olguín et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Cytotoxic immunotherapy strategies for cancer: Mechanisms and clinical development

(2011) Laura K. Aguilar et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Case of Rhabdomyosarcoma Presenting With Myasthenia Gravis

(2011) Qurrat U. Mehmood et al.   JOURNAL OF CLINICAL ONCOLOGY

Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737

(2011) David J. Fitzgerald et al.   LEUKEMIA & LYMPHOMA

The improvement of an anti-CD22 immunotoxin

(2011) Seiji Kawa et al.   mAbs

MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality

(2011) Rossella Rota et al.   Molecular Cancer

Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide

(2011) Alan Melcher et al.   MOLECULAR THERAPY

Current status of the congenital myasthenic syndromes

(2011) Andrew G. Engel   NEUROMUSCULAR DISORDERS

Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice

(2011) F Nitzki et al.   ONCOGENE

Soft tissue sarcoma across the age spectrum: A population-based study from the surveillance epidemiology and end results database

(2011) Andrea Ferrari et al.   PEDIATRIC BLOOD & CANCER

Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy

(2011) Joanna L. Meadors et al.   PEDIATRIC BLOOD & CANCER

CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres

(2011) Dagmar Walter et al.   PLoS One

Antibody drug conjugates — Trojan horses in the war on cancer

(2011) U. Iyer et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Thymoma and paraneoplastic myasthenia gravis

(2010) A. Marx et al.   AUTOIMMUNITY

Survivin and IAP proteins in cell-death mechanisms

(2010) Dario C. Altieri   BIOCHEMICAL JOURNAL

CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attack

(2010) M Chmielewski et al.   GENE THERAPY

A Human Recombinant Autoantibody-Based Immunotoxin Specific for the Fetal Acetylcholine Receptor Inhibits Rhabdomyosarcoma Growth In Vitro and in a Murine Transplantation Model

(2010) S. Gattenlöhner et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients

(2010) Julien Fourcade et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The Autoimmune Regulator AIRE in Thymoma Biology: Autoimmunity and Beyond

(2010) Alexander Marx et al.   Journal of Thoracic Oncology

Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo

(2010) S Landmeier et al.   LEUKEMIA

Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity

(2010) Frédéric Chibon et al.   NATURE MEDICINE

Adoptive T-Zell-Therapie des Rhabdomyosarkoms

(2010) K. Simon-Keller et al.   PATHOLOGE

WT1 peptide immunotherapy for cancer in children and young adults

(2010) Yoshiko Hashii et al.   PEDIATRIC BLOOD & CANCER

Many routes to the same destination: lessons from skeletal muscle development

(2010) Gi Fay Mok et al.   REPRODUCTION

Childhood Rhabdomyosarcoma: New Insight on Biology and Treatment

(2010) Winston W. Huh et al.   Current Oncology Reports

Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis

(2009) Elai Davicioni et al.   AMERICAN JOURNAL OF PATHOLOGY

Adult-type Rhabdomyosarcoma: Analysis of 57 Cases With Clinicopathologic Description, Identification of 3 Morphologic Patterns and Prognosis

(2009) Nathalie Stock et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells

(2009) M Hirotsu et al.   BRITISH JOURNAL OF CANCER

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

(2009) Celestia S. Higano et al.   CANCER

Translocation (2;8)(q35;q13): a recurrent abnormality in congenital embryonal rhabdomyosarcoma

(2009) Aurelia Meloni-Ehrig et al.   CANCER GENETICS AND CYTOGENETICS

Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy

(2009) Mrudula Mathew et al.   CANCER SCIENCE

Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/- Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN- 2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696

(2009) J. M. Kirkwood et al.   CLINICAL CANCER RESEARCH

Rhabdomyosarcoma in children

(2009) Andrea Hayes-Jordan et al.   CURRENT OPINION IN PEDIATRICS

Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T Cells

(2009) Claudia Wrzesinski et al.   JOURNAL OF IMMUNOTHERAPY

ENDPLATE DESTRUCTION DUE TO MATERNAL ANTIBODIES IN ARTHROGRYPOSIS MULTIPLEX CONGENITA

(2009) J. Reimann et al.   NEUROLOGY

Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function

(2009) Edson X. Albuquerque et al.   PHYSIOLOGICAL REVIEWS

Integrated Functions of Pax3 and Pax7 in the Regulation of Proliferation, Cell Size and Myogenic Differentiation

(2009) Charlotte A. Collins et al.   PLoS One

Antigen-specific Apheresis of Pathogenic Autoantibodies from Myasthenia Gravis Sera

(2008) Socrates J. Tzartos et al.   Annals of the New York Academy of Sciences

The MicroRNA miR-1 Regulates a MEF-2-Dependent Retrograde Signal at Neuromuscular Junctions

(2008) David J. Simon et al.   CELL

A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas

(2008) C. L. Mackall et al.   CLINICAL CANCER RESEARCH

Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains

(2008) Paraskevi Zisimopoulou et al.   JOURNAL OF NEUROIMMUNOLOGY

Preferential expression of AChR ε-subunit in thymomas from patients with myasthenia gravis

(2008) Calman A. MacLennan et al.   JOURNAL OF NEUROIMMUNOLOGY

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

(2008) Roberto Cattaneo et al.   NATURE REVIEWS MICROBIOLOGY